Equine Metabolic Syndrome

Veterinary Clinics of North America - Equine Practice

Volumn 27, Issue 1, 2011, Pages 73-92

  Frank, Nicholas ^a,b  

^a UNIVERSITY OF TENNESSEE   (United States)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Hyperinsulinemia; Insulin resistance; Laminitis; Obesity; Regional adiposity

Indexed keywords

ANIMAL; ANIMAL DISEASE; ANIMAL LAMENESS; BREEDING; FEMALE; GLUCOSE BLOOD LEVEL; HORSE; HORSE DISEASE; INSULIN RESISTANCE; LOW CALORY DIET; MALE; METABOLIC SYNDROME X; METABOLISM; OBESITY; REVIEW;

ANIMALS; BLOOD GLUCOSE; BREEDING; DIET, REDUCING; FEMALE; HORSE DISEASES; HORSES; INSULIN RESISTANCE; LAMENESS, ANIMAL; MALE; METABOLIC SYNDROME X; OBESITY;

EQUIDAE;

EID: 79952340683     PISSN: 07490739     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cveq.2010.12.004     Document Type: Review

References (72)

1. Johnson P.J. The equine metabolic syndrome peripheral Cushing's syndrome. Vet Clin North Am Equine Pract 2002, 18(2):271-293.
2. Frank N., Geor R.J., Bailey S.R., et al. Equine metabolic syndrome. J Vet Intern Med 2010, 24(3):467-475.
3. Bruce K.D., Hanson M.A. The developmental origins, mechanisms, and implications of metabolic syndrome. J Nutr 2010, 140(3):648-652.
4. Treiber K.H., Kronfeld D.S., Hess T.M., et al. Evaluation of genetic and metabolic predispositions and nutritional risk factors for pasture-associated laminitis in ponies. J Am Vet Med Assoc 2006, 228(10):1538-1545.
5. Carter R.A., Treiber K.H., Geor R.J., et al. Prediction of incipient pasture-associated laminitis from hyperinsulinaemia, hyperleptinaemia and generalised and localised obesity in a cohort of ponies. Equine Vet J 2009, 41(2):171-178.
6. Frank N., Elliott S.B., Brandt L.E., et al. Physical characteristics, blood hormone concentrations, and plasma lipid concentrations in obese horses with insulin resistance. J Am Vet Med Assoc 2006, 228(9):1383-1390.
7. Cartmill J.A., Thompson D.L., Storer W.A., et al. Endocrine responses in mares and geldings with high body condition scores grouped by high vs. low resting leptin concentrations. J Anim Sci 2003, 81(9):2311-2321.
8. Kearns C.F., McKeever K.H., Roegner V., et al. Adiponectin and leptin are related to fat mass in horses. Vet J 2006, 172(3):460-465.
9. Vick M.M., Adams A.A., Murphy B.A., et al. Relationships among inflammatory cytokines, obesity, and insulin sensitivity in the horse. J Anim Sci 2007, 85(5):1144-1155.
10. Bailey S.R., Habershon-Butcher J.L., Ransom K.J., et al. Hypertension and insulin resistance in a mixed-breed population of ponies predisposed to laminitis. Am J Vet Res 2008, 69(1):122-129.
11. Watson T.D., Packard C.J., Shepherd J. Plasma lipid transport in the horse (Equus caballus). Comp Biochem Physiol B 1993, 106(1):27-34.
12. Geor R.J. Current concepts on the pathophysiology of pasture-associated laminitis. Vet Clin North Am Equine Pract 2010, 26(2):265-276.
13. Longland A.C., Byrd B.M. Pasture nonstructural carbohydrates and equine laminitis. J Nutr 2006, 136(Suppl 7):2099S-2102S.
14. Asplin K.E., Sillence M.N., Pollitt C.C., et al. Induction of laminitis by prolonged hyperinsulinaemia in clinically normal ponies. Vet J 2007, 174(3):530-535.
15. de Laat M.A., McGowan C.M., Sillence M.N., et al. Equine laminitis: induced by 48 h hyperinsulinaemia in Standardbred horses. Equine Vet J 2010, 42(2):129-135.
16. Elliott J., Bailey S.R. Gastrointestinal derived factors are potential triggers for the development of acute equine laminitis. J Nutr 2006, 136(Suppl 7):2103S-2107S.
17. Bailey S.R., Adair H.S., Reinemeyer C.R., et al. Plasma concentrations of endotoxin and platelet activation in the developmental stage of oligofructose-induced laminitis. Vet Immunol Immunopathol 2009, 129(3-4):167-173.
18. van Eps A.W., Pollitt C.C. Equine laminitis induced with oligofructose. Equine Vet J 2006, 38(3):203-208.
19. Kalck K.A., Frank N., Elliott S.B., et al. Effects of low-dose oligofructose treatment administered via nasogastric intubation on induction of laminitis and associated alterations in glucose and insulin dynamics in horses. Am J Vet Res 2009, 70(5):624-632.
20. Toth F., Frank N., Chameroy K.A., et al. Effects of endotoxaemia and carbohydrate overload on glucose and insulin dynamics and the development of laminitis in horses. Equine Vet J 2009, 41(9):852-858.
21. Henneke D.R., Potter G.D., Kreider J.L., et al. Relationship between condition score, physical measurements and body fat percentage in mares. Equine Vet J 1983, 15(4):371-372.
22. Carter R.A., Geor R.J., Burton S.W., et al. Apparent adiposity assessed by standardised scoring systems and morphometric measurements in horses and ponies. Vet J 2009, 179(2):204-210.
23. Prentice A.M. Early influences on human energy regulation: thrifty genotypes and thrifty phenotypes. Physiol Behav 2005, 86(5):640-645.
24. Armstrong C., Streeter C., Brooks S. Identification of SNPs within MCR4 as a candidate for obesity in the horse. J Equine Vet Sci 2009, 29(5):322-323.
25. Ozanne S.E., Hales C.N. Early programming of glucose-insulin metabolism. Trends Endocrinol Metab 2002, 13(9):368-373.
26. Ousey J.C., Fowden A.L., Wilsher S., et al. The effects of maternal health and body condition on the endocrine responses of neonatal foals. Equine Vet J 2008, 40(7):673-679.
27. George L.A., Staniar W.B., Treiber K.H., et al. Insulin sensitivity and glucose dynamics during pre-weaning foal development and in response to maternal diet composition. Domest Anim Endocrinol 2009, 37(1):23-29.
28. Treiber K.H., Kronfeld D.S., Geor R.J. Insulin resistance in equids: possible role in laminitis. J Nutr 2006, 136(Suppl 7):2094S-2098S.
29. Treiber K.H., Kronfeld D.S., Hess T.M., et al. Use of proxies and reference quintiles obtained from minimal model analysis for determination of insulin sensitivity and pancreatic beta-cell responsiveness in horses. Am J Vet Res 2005, 66(12):2114-2121.
30. Carter R.A., McCutcheon L.J., George L.A., et al. Effects of diet-induced weight gain on insulin sensitivity and plasma hormone and lipid concentrations in horses. Am J Vet Res 2009, 70(10):1250-1258.
31. Durham A.E., Hughes K.J., Cottle H.J., et al. Type 2 diabetes mellitus with pancreatic b-cell dysfunction in 3 horses confirmed with minimal model analysis. Equine Vet J 2009, 41(9):924-929.
32. Tóth F., Frank N., Martin-Jiménez T., et al. Measurement of C-peptide concentrations and responses to somatostatin, glucose infusion, and insulin resistance in horses. Equine Vet J 2010, 42:149-155.
33. Samuel V.T., Petersen K.F., Shulman G.I. Lipid-induced insulin resistance: unravelling the mechanism. Lancet 2010, 375(9733):2267-2277.
34. Stokes A.M., Keowen M.L., McGeachy M., et al. Potential role of the Toll-like receptor signaling pathway in equine laminitis [abstract]. J Equine Vet Sci 2010, 30(2):113-114.
35. Kahn C.R. Insulin resistance, insulin insensitivity, and insulin unresponsiveness: a necessary distinction. Metabolism 1978, 27(12 Suppl 2):1893-1902.
36. Waller AP, Kohler K, Burns TA, et al. Regulation of glucose transport: novel insights into the pathogenesis of insulin resistance in horses. In: ACVIM forum proceedings. Anaheim (CA); 2010. p. 198.
37. Quinn R.W., Burk A.O., Hartsock T.G., et al. Insulin sensitivity in Thoroughbred geldings: effect of weight gain, diet, and exercise on insulin sensitivity in Thoroughbred geldings. J Equine Vet Sci 2008, 28(12):728-738.
38. Van Weyenberg S., Hesta M., Buyse J., et al. The effect of weight loss by energy restriction on metabolic profile and glucose tolerance in ponies. J Anim Physiol Anim Nutr (Berl) 2008, 92(5):538-545.
39. Randle P.J., Garland P.B., Newsholme E.A., et al. The glucose fatty acid cycle in obesity and maturity onset diabetes mellitus. Ann N Y Acad Sci 1965, 131(1):324-333.
40. Shulman G.I. Cellular mechanisms of insulin resistance. J Clin Invest 2000, 106(2):171-176.
41. Radin M.J., Sharkey L.C., Holycross B.J. Adipokines: a review of biological and analytical principles and an update in dogs, cats, and horses. Vet Clin Pathol 2009, 38(2):136-156.
42. Burns T.A., Geor R.J., Mudge M.C., et al. Proinflammatory cytokine and chemokine gene expression profiles in subcutaneous and visceral adipose tissue depots of insulin-resistant and insulin-sensitive light breed horses. J Vet Intern Med 2010, 24(4):932-939.
43. Burns T.A., Geor R.J., Mudge M.C., et al. Characterization of adipose tissue macrophage infiltration in insulin-resistant and insulin-sensitive light breed horses [abstract]. J Vet Intern Med 2010, 24(3):782.
44. Despres J.P., Lemieux I., Bergeron J., et al. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol 2008, 28(6):1039-1049.
45. Grundy S.M. Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol 2008, 28(4):629-636.
46. De Sousa Peixoto R.A., Turban S., Battle J.H., et al. Preadipocyte 11beta-hydroxysteroid dehydrogenase type 1 is a keto-reductase and contributes to diet-induced visceral obesity in vivo. Endocrinology 2008, 149(4):1861-1868.
47. Santosa S., Jensen M.D. Why are we shaped differently, and why does it matter?. Am J Physiol Endocrinol Metab 2008, 295(3):E531-E535.
48. Schott H.C., Graves E.A., Refsal K.R., et al. Diagnosis and treatment of pituitary pars intermedia dysfunction (classical Cushing's disease) and metabolic syndrome (peripheral Cushing's syndrome) in horses. Adv Vet Dermatol 2005, 5:159-169.
49. Houseknecht K.L., Spurlock M.E. Leptin regulation of lipid homeostasis: dietary and metabolic implications. Nutr Res Rev 2003, 16(1):83-96.
50. Chen D., Garg A. Monogenic disorders of obesity and body fat distribution. J Lipid Res 1999, 40(10):1735-1746.
51. Gentry L.R., Thompson D.L., Gentry G.T., et al. The relationship between body condition, leptin, and reproductive and hormonal characteristics of mares during the seasonal anovulatory period. J Anim Sci 2002, 80(10):2695-2703.
52. Caltabilota T.J., Earl L.R., Thompson D.L., et al. Hyperleptinemia in mares and geldings: assessment of insulin sensitivity from glucose responses to insulin injection. J Anim Sci 2010, 88(9):2940-2949.
53. Wang Y., Zhou M., Lam K.S., et al. Protective roles of adiponectin in obesity-related fatty liver diseases: mechanisms and therapeutic implications. Arq Bras Endocrinol Metabol 2009, 53(2):201-212.
54. Wooldridge A.A., Taylor D.R., Zhong Q., et al. High molecular weight adiponectin is reduced in horses with obesity and inflammatory disease [abstract]. J Vet Intern Med 2010, 24(3):781.
55. Wickham E.P., Cheang K.I., Clore J.N., et al. Total and high-molecular weight adiponectin in women with the polycystic ovary syndrome. Metabolism 2010, [Epub ahead of print]. DOI:101016/j.metabol.2010.02.019.
56. Almeda-Valdes P., Cuevas-Ramos D., Mehta R., et al. Total and high molecular weight adiponectin have similar utility for the identification of insulin resistance. Cardiovasc Diabetol 2010, 9:26.
57. Eiler H., Frank N., Andrews F.M., et al. Physiologic assessment of blood glucose homeostasis via combined intravenous glucose and insulin testing in horses. Am J Vet Res 2005, 66(9):1598-1604.
58. Firshman A.M., Valberg S.J. Factors affecting clinical assessment of insulin sensitivity in horses. Equine Vet J 2007, 39(6):567-575.
59. Schuver A., Frank N., Chameroy K., et al. Use of an oral sugar test to assess insulin sensitivity in healthy and insulin-resistant horses [abstract]. J Vet Intern Med 2010, 24(3):780.
60. Dugdale A.H., Curtis G.C., Cripps P., et al. Effect of dietary restriction on body condition, composition and welfare of overweight and obese pony mares. Equine Vet J 2010, 42(7):600-610.
61. Geor R.J., Harris P. Dietary management of obesity and insulin resistance: countering risk for laminitis. Vet Clin North Am Equine Pract 2009, 25(1):51-65. vi.
62. Frank N., Buchanan B.R., Elliott S.B. Effects of long-term oral administration of levothyroxine sodium on serum thyroid hormone concentrations, clinicopathologic variables, and echocardiographic measurements in healthy adult horses. Am J Vet Res 2008, 69(1):68-75.
63. Frank N., Elliott S.B., Boston R.C. Effects of long-term oral administration of levothyroxine sodium on glucose dynamics in healthy adult horses. Am J Vet Res 2008, 69(1):76-81.
64. Sommardahl C.S., Frank N., Elliott S.B., et al. Effects of oral administration of levothyroxine sodium on serum concentrations of thyroid gland hormones and responses to injections of thyrotropin-releasing hormone in healthy adult mares. Am J Vet Res 2005, 66(6):1025-1031.
65. Tóth F., Frank N., Geor R.J., et al. Effects of pretreatment with dexamethasone or levothyroxine sodium on endotoxin-induced alterations in glucose and insulin dynamics in horses. Am J Vet Res 2010, 71(1):60-68.
66. Kim Y.D., Park K.G., Lee Y.S., et al. Metformin inhibits hepatic gluconeogenesis through AMP-activated protein kinase-dependent regulation of the orphan nuclear receptor SHP. Diabetes 2008, 57(2):306-314.
67. Musi N., Hirshman M.F., Nygren J., et al. Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes. Diabetes 2002, 51(7):2074-2081.
68. Saeedi R., Parsons H.L., Wambolt R.B., et al. Metabolic actions of metformin in the heart can occur by AMPK-independent mechanisms. Am J Physiol Heart Circ Physiol 2008, 294(6):H2497-H2506.
69. Durham A.E., Rendle D.I., Newton J.E. The effect of metformin on measurements of insulin sensitivity and beta cell response in 18 horses and ponies with insulin resistance. Equine Vet J 2008, 40(5):493-500.
70. Hustace J.L., Firshman A.M., Mata J.E. Pharmacokinetics and bioavailability of metformin in horses. Am J Vet Res 2009, 70(5):665-668.
71. Chameroy K., Frank N., Elliott S.B. Effects of metformin hydrochloride on glucose dynamics during transition to grass paddocks in insulin-resistant horses [abstract]. J Vet Intern Med 2010, 24(3):690.
72. Wearn J.G., Suagee J.K., Crisman M.V., et al. Effects of the insulin sensitizing drug pioglitazone on indices of insulin homeostasis in horses following endotoxin administration [abstract]. J Vet Intern Med 2010, 24(3):709.